IPO

DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal secures €345 million debt funding from Blackrock, Pricoa Private Capital, UniCredit and other institutional investors

Thursday, September 23, 2021 - 9:03am

DGAP-News: Heliad Equity Partners GmbH & Co. KGaA

Key Points: 
  • DGAP-News: Heliad Equity Partners GmbH & Co. KGaA
    Heliad Equity Partners GmbH & Co. KGaA: Enpal secures 345 million debt funding from Blackrock, Pricoa Private Capital, UniCredit and other institutional investors
    The issuer is solely responsible for the content of this announcement.
  • Enpal secures 345 million debt funding from Blackrock, Pricoa Private Capital, UniCredit and other institutional investors
    Frankfurt am Main, 23.
  • September 2021 - Heliad's portfolio company, Enpal GmbH, secures debt commitments in the amount of 275 million from Blackrock, Pricoa Private Capital, as well as UniCredit.
  • In addition, the company received mezzanine funding in the amount of 70 million from another institutional investor.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yalla, Sesen Bio, and loanDepot and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:18am

On May 19, 2021, Swan Street Research (Swan Street) published a report (the Swan Street Report) addressingYalla, entitled IsYallaGroup a Multi $B Fraud?

Key Points: 
  • On May 19, 2021, Swan Street Research (Swan Street) published a report (the Swan Street Report) addressingYalla, entitled IsYallaGroup a Multi $B Fraud?
  • On this news, the price ofYallashares fell $1.31 per share, or 7.15%, to close at $17.01 per share on May 19, 2021.
  • The next day, May 20, 2021, analyst The Bear Cave issued a report entitled, "Problems atYallaGroup," and Gotham City Research also tweeted that it was shortingYallashares.
  • For more information on the loanDepot class action go to: https://bespc.com/cases/LDI
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zymergen, Annovis Bio, and Cassava Sciences and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:08am

In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.

Key Points: 
  • In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.
  • As a result, Zymergen no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
  • For more information on the Zymergen class action go to: https://bespc.com/cases/ZY
    On July 28, 2021, after the market closed,Annovisreported interim clinical data from its Phase 2a trial.
  • For more information on the Cassava Sciences class action go to: https://bespc.com/cases/SAVA
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ardelyx, SelectQuote, Katapult, and Waterdrop Sciences and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:08am

On this news, the Companys share price declined, falling $9.71 per share, or nearly 74%, to close at $2.01 per share on July 20, 2021.

Key Points: 
  • On this news, the Companys share price declined, falling $9.71 per share, or nearly 74%, to close at $2.01 per share on July 20, 2021.
  • Furthermore, Waterdrop had suffered rapidly accelerating operating losses in the first quarter of 2021 which was completed weeksbeforethe IPO.
  • For more information on the Waterdrop class action go to: https://bespc.com/cases/WDH
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Concho, ATI, HyreCar, and The Honest Company and Encourages Investors to Contact the Firm

Thursday, September 23, 2021 - 2:03am

On July 31, 2019, after the close of trading, Concho released its financial results for the second quarter 2019.

Key Points: 
  • On July 31, 2019, after the close of trading, Concho released its financial results for the second quarter 2019.
  • ThoughATIwas implementing certain remedial actions, the Company reduced its fiscal 2021 forecast due to the foregoing factors.
  • Honest Company also disclosed that its Diapers and Wipes category revenue declined 2% compared to the second quarter of 2020.
  • For more information on the Honest Company class action go to: https://bespc.com/cases/HNST
    About Bragar Eagel & Squire, P.C.

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Business Update

Wednesday, September 22, 2021 - 9:05pm

Business highlights for the fourth quarter of fiscal year 2021 and recent weeks include the following:

Key Points: 
  • Business highlights for the fourth quarter of fiscal year 2021 and recent weeks include the following:
    Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial.
  • Operating expenses in the fourth quarter of fiscal 2021 were $2,484,705 compared with $173,351 in the same period in fiscal 2020.
  • Net loss in the fourth quarter of fiscal 2021 was $29,111,739, or $(1.59) per share, compared with a net loss of $174,637, or $(0.01) per share, in the fourth quarter of fiscal 2020.
  • Except as required by federal securities law, Anebulo Pharmaceuticals undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.

Scott+Scott Attorneys at Law LLP Announces Investigation into LifeStance Health Group, Inc. (LFST)

Wednesday, September 22, 2021 - 7:10pm

If you purchased or otherwise own LifeStance Health shares, and have suffered a loss, you are encouraged to contact Jonathan Zimmerman at (888) 398-9312 for more information.

Key Points: 
  • If you purchased or otherwise own LifeStance Health shares, and have suffered a loss, you are encouraged to contact Jonathan Zimmerman at (888) 398-9312 for more information.
  • LifeStance Health claims to have built one of the nations largest outpatient mental health platforms based on number of clinicians and geographic scale.
  • On or about June 10, 2021, LifeStance Health conducted its IPO, making available 40 million shares to the general public at $18 per share for gross proceeds of $720 million.
  • If you purchased or otherwise own LifeStance Health shares, and you wish to discuss this investigation, please contact attorney Jonathan Zimmerman at (888) 398-9312, or at jzimmerman@scott-scott.com , or visit the LifeStance Health investigation page on our website at https://scott-scott.com/sec-investigation/lifestance-health-group-inc/ .

Affluent Medical : Financial results for the first half of 2021 and main clinical update.

Wednesday, September 22, 2021 - 6:56pm

During the first half of 2021, purchases consumed fell by 158 thousand compared to the first half of 2020.

Key Points: 
  • During the first half of 2021, purchases consumed fell by 158 thousand compared to the first half of 2020.
  • On 9 June 2021, Affluent Medical announced the success of its IPO on the regulated market of Euronext Paris.
  • Starting in 2018 he broadened his field of expertise by engaging in various entrepreneurial projects before joining Affluent Medical.
  • Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas.

ROSEN, A TOP RANKED FIRM, Encourages The Honest Company, Inc. Investors to Secure Counsel Before Important November 15 Deadline in Securities Class Action – HNST

Wednesday, September 22, 2021 - 4:19pm

WHAT TO DO NEXT: To join The Honest Company class action, go to http://www.rosenlegal.com/cases-register-2161.html or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join The Honest Company class action, go to http://www.rosenlegal.com/cases-register-2161.html or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

CoinFund Appoints Top Venture Capitalist David Pakman as Managing Partner

Wednesday, September 22, 2021 - 3:00pm

CoinFund , a leading crypto and blockchain investment firm is proud to welcome David Pakman as Managing Partner focused on expanding the firms growth-stage venture capital initiatives.

Key Points: 
  • CoinFund , a leading crypto and blockchain investment firm is proud to welcome David Pakman as Managing Partner focused on expanding the firms growth-stage venture capital initiatives.
  • David comes to CoinFund after 13 years with Venrock , the iconic venture firm focused on investing in emerging technologies.
  • He personally invested in Coinbase prior to their IPO and was named the 55th top venture capitalist in the world by CB Insights.
  • David led Venrocks efforts in crypto and had the insight to partner with CoinFund early on.